Population
Patients with degenerated bioprosthetic aortic valves
Design
Cohort
Follow-up
1 year
Authors
Loading...
Valve-in-valve TAVR yields variable survival by valve size and stenosis type; leaves open need for refined selection and randomized trials.
Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic valves yields an 83.2% 1-year survival rate, though outcomes are worse in patients with small bioprostheses or predominant stenosis.
Dvir et al. (2014) studied this question.